BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36054012)

  • 1. Can charcoal hemoperfusion treatment be an option for pediatric MIS-C patients? A single-center experience in a tertiary pediatric intensive care unit.
    Varol F; Guney Sahin E; Cengiz M; Kilic A; Altas ZM; Guven S; Çam H
    J Clin Apher; 2022 Oct; 37(5):489-496. PubMed ID: 36054012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
    García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R;
    Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparative Study of Children with MIS-C between Admitted to the Pediatric Intensive Care Unit and Pediatric Ward: A One-Year Retrospective Study.
    Kıymet E; Böncüoğlu E; Şahinkaya Ş; Cem E; Çelebi MY; Düzgöl M; Kara AA; Arıkan KÖ; Vuran GT; Yılmazer MM; Sandal ÖS; Ağın H; Pirinç N; Bayram N; Devrim İ
    J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34931251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and management of patients with SARS-CoV2 infection admitted to pediatric intensive care units: Data analysis of the Spanish national multicenter registry.
    Slöcker Barrio M; Belda Hofheinz S; Guitart Pardellans C; García-Salido A; de Carlos Vicente JC; Cuervas-Mons Tejedor M; Hernández Yuste A; Jiménez Olmos A; Morteruel Arizcuren E; García-Besteiro M; Calvo Monge C; Rodríguez Rubio M; Roca Pascual D; Bermúdez Barrezueta L; Martínez Padilla C; Huidobro Labarga B; Oulego-Erroz I; Sanchíz Cárdenas S; Rey Galan C; Holanda Peña MS; González Navarro P; Cortés RG;
    Pediatr Pulmonol; 2023 Oct; 58(10):2916-2929. PubMed ID: 37493137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A descriptive study on multisystem inflammatory syndrome in children in a single center in West Michigan.
    Shabab J; Dubisky A; Singh A; Crippen M; Abulaban K; Aldrich A
    Pediatr Rheumatol Online J; 2021 Dec; 19(1):172. PubMed ID: 34915906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical manifestations and outcomes associated with PICU admission in children with multisystem inflammatory syndrome in Taiwan: A retrospective cohort study.
    Tseng CT; Lin JJ; Huang JL; Chiu CH; Wu CY
    Int J Rheum Dis; 2024 Jan; 27(1):e14970. PubMed ID: 37947261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Multi-inflammatory Syndrome in Children Temporally Related to COVID 19-Clinical Course, Laboratory Profile and Outcomes from a North Indian PICU.
    Chattopadhyay A; Saigal Kalra K; Saikia D; Yadav V; Chouksey J; Jajoo M; Sherwal BL
    J Intensive Care Med; 2022 Sep; 37(9):1229-1237. PubMed ID: 35469487
    [No Abstract]   [Full Text] [Related]  

  • 8. Characteristics and predictors of outcomes of critically Ill children with SARS-CoV-2 infection - the PICU experience.
    Kazi MA; Roychowdhury S; Ghosh S; Mahapatra MK; Bhakta S; Konar MC; Sarkar M
    J Pediatr (Rio J); 2022; 98(5):504-512. PubMed ID: 35139344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early is superior to late plasma exchange for severe multisystem inflammatory syndrome in children.
    Katlan B; Kesici S; Karacanoğlu D; Oygar PD; Ünal Yüksekgönül A; Şener S; Aykan HH; Özsurekçi Y; Özen S; Bayrakci B
    J Clin Apher; 2022 Jun; 37(3):281-291. PubMed ID: 35174897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center.
    Sözeri B; Çağlayan Ş; Atasayan V; Ulu K; Coşkuner T; Pelin Akbay Ö; Hasbal Akkuş C; Atay G; Salı E; Karacan M; Öner T; Erdoğan S; Demir F
    Postgrad Med; 2021 Nov; 133(8):994-1000. PubMed ID: 34605352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and Outcomes of Critically Ill Children With Multisystem Inflammatory Syndrome.
    Snooks K; Scanlon MC; Remy KE; Shein SL; Klein MJ; Zee-Cheng J; Rogerson CM; Rotta AT; Lin A; McCluskey CK; Carroll CL
    Pediatr Crit Care Med; 2022 Nov; 23(11):e530-e535. PubMed ID: 35994614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive Care Needs and Short-Term Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience from North India.
    Angurana SK; Awasthi P; Thakur A; Randhawa MS; Nallasamy K; Kumar MR; Naganur S; Kumar M; Goyal K; Ghosh A; Bansal A; Jayashree M
    J Trop Pediatr; 2021 Jul; 67(3):. PubMed ID: 34170328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series Experience in a Tertiary Care Hospital of Southern Turkey.
    Tolunay O; Çelik Ü; Arslan İ; Orgun A; Demir H; Demir O; Dağdelen EÇ
    J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34028528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Profile and Outcome of Children Admitted with Multisystem Inflammatory Syndrome (MIS-C) in a Tertiary Hospital.
    Singh SK; Sah VK; Pyakurel A
    Kathmandu Univ Med J (KUMJ); 2023; 21(82):175-179. PubMed ID: 38628011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multisystem Inflammatory Syndrome in Children (MIS-C).
    Patel JM
    Curr Allergy Asthma Rep; 2022 May; 22(5):53-60. PubMed ID: 35314921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Disease in Presenting to the Pediatric Emergency Department: A Multicenter Study of 8886 Cases.
    Duman M; Şık N; Tekşam Ö; Akça H; Kurt F; Çağlar AA; Yıldız LA; Taşar MA; Fidancı İ; Yayla BCC; Yılmaz D; Güngör E; Demir Ş; Çokuğraş H; Cebeci SO; Önal P; Saz EU; Yurtseven A; Uysalol M; Yıldız R; Gümüş S; Bal A; Bayturan SŞ; Zengin N; Atik S; Çiftdoğan DY; Berksoy E; Çiçek A; Şahin S; Kızıl MC; Kara Y; Apa H; Ulusoy E; Kara AA; Yesil E; Erdem M; Turan C; Arslanoglu S; Duyu M; Besli GE; Arslan G; Oflu AT; Çeleğen M; Buldu E; Pişkin İE; Kardeş H; Yılmaz HL; Yıldızdaş D; Gökulu G; Çay P; Özer U; Güleryüz OD; Çolak Ö; Güneysu ST
    Am J Emerg Med; 2022 Sep; 59():133-140. PubMed ID: 35849960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean.
    Ozsurekci Y; Gürlevik S; Kesici S; Akca UK; Oygar PD; Aykac K; Karacanoglu D; Sarıtas Nakip O; Ilbay S; Katlan B; Ertugrul İ; Cengiz AB; Basaran O; Cura Yayla BC; Karakaya J; Bilginer Y; Bayrakci B; Ceyhan M; Ozen S
    Clin Rheumatol; 2021 Aug; 40(8):3227-3237. PubMed ID: 33576926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Biological Agents in the Treatment of SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children.
    Çelikel E; Tekin ZE; Aydin F; Emeksiz S; Uyar E; Özcan S; Perk O; Sezer M; Tekgöz N; Coşkun S; Güngörer V; Gül AEK; Bayhan Gİ; Özbek N; Azili MN; Acar BÇ
    J Clin Rheumatol; 2022 Mar; 28(2):e381-e387. PubMed ID: 33843774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 variants are associated with different clinical courses in children with MIS-C.
    Moreno Rojas AF; Bainto E; Harvey H; Tremoulet AH; Burns JC; Dummer KB
    World J Pediatr; 2024 Feb; 20(2):143-152. PubMed ID: 38133726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.
    Feldstein LR; Tenforde MW; Friedman KG; Newhams M; Rose EB; Dapul H; Soma VL; Maddux AB; Mourani PM; Bowens C; Maamari M; Hall MW; Riggs BJ; Giuliano JS; Singh AR; Li S; Kong M; Schuster JE; McLaughlin GE; Schwartz SP; Walker TC; Loftis LL; Hobbs CV; Halasa NB; Doymaz S; Babbitt CJ; Hume JR; Gertz SJ; Irby K; Clouser KN; Cvijanovich NZ; Bradford TT; Smith LS; Heidemann SM; Zackai SP; Wellnitz K; Nofziger RA; Horwitz SM; Carroll RW; Rowan CM; Tarquinio KM; Mack EH; Fitzgerald JC; Coates BM; Jackson AM; Young CC; Son MBF; Patel MM; Newburger JW; Randolph AG;
    JAMA; 2021 Mar; 325(11):1074-1087. PubMed ID: 33625505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.